Cogene Ventures
9
37M
6
0.43
0.33
5
- Stages of investment
- Areas of investment
Summary
Cogene Ventures is the famous VC, which was founded in 2000. The main department of described VC is located in the Houston. The venture was found in North America in United States.
The standard case for the fund is to invest in rounds with 7 partakers. Despite the Cogene Ventures, startups are often financed by MDS Capital, U.S. Venture Partners (USVP), RBC Venture Partners. The meaningful sponsors for the fund in investment in the same round are Vulcan Capital, U.S. Venture Partners (USVP), Schroder Ventures. In the next rounds fund is usually obtained by Sofinnova Investments, RCT BioVentures, Novartis Venture Fund.
Among the various public portfolio startups of the fund, we may underline Catalyst Biosciences, Raven Biotechnologies, Neuromed Pharmaceuticals The fund has no exact preference in a number of founders of portfolio startups. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. We can highlight the next thriving fund investment areas, such as Life Science, Health Care. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund.
Opposing the other organizations, this Cogene Ventures works on 51 percentage points more the average amount of lead investments. The increased amount of exits for fund were in 2011. The fund is constantly included in less than 2 deals per year. The high activity for fund was in 2003. The usual things for fund are deals in the range of 10 - 50 millions dollars.
Investments analytics
Analytics
- Total investments
- 9
- Lead investments
- 0
- Exits
- 5
- Rounds per year
- 0.43
- Follow on index
- 0.33
- Investments by industry
- Biotechnology (9)
- Health Care (7)
- Medical (4)
- Therapeutics (4)
- Pharmaceutical (3) Show 10 more
- Investments by region
-
- United States (7)
- Canada (2)
- Peak activity year
- 2004
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 23
- Avg. valuation at time of investment
- 1M
- Group Appearance index
- 1.00
- Avg. company exit year
- 12
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Neuromed Pharmaceuticals | 04 Nov 2003 | Biotechnology, Information Technology, Health Care, Cyber Security, Project Management, Telecommunications, Enterprise Applications, Biopharma | Late Stage Venture | 32M | British Columbia, Vancouver, Canada |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.